Intercept Pharmaceuticals to Host 2013 Full Year Financial Results and Business Update Conference Call on March 17

[GlobeNewswire] – NEW YORK — Intercept Pharmaceuticals, Inc. (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver … more

View todays social media effects on ICPT

View the latest stocks trending across Twitter. Click to view dashboard

See who Intercept is hiring next, click here to view